Anna is from England and recently finished her undergraduate degree. She has an interest in medicine and enjoys writing. In her spare time she likes to cook, hike, and hang out with cats.
9% Copyscape An investigational drug called CLR 131 has received Rare Pediatric Disease Designation from the US FDA for the treatment of Ewing’s sarcoma. The source press release can be…
Continue ReadingThe FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma
A research team led by scientists from the Beth Israel Deaconess Medical Center (BIDMC) have found that arsenic, in combination with the drug all-trans retinoic acid (ATRA), may have the potential…
Continue ReadingA Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say
The award-winning actor Alan Alda has shared his diagnosis of Parkinson’s disease during an interview on the CBS This Morning show. The source video of the interview can be found here on…
Continue ReadingAward-Winning Actor Alan Alda Has Spoken Out About His Parkinson’s Disease Diagnosis
A recently published study in the Journal of Biosciences and Medicines has concluded that orthoses may help to improve the gait and balance of patients with Charcot-Marie-Tooth disease. Orthoses are…
Continue ReadingOrthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study
A recent study into Periodic Fever, Aphtous stomatitis, Pharyngitis and Adenitis (PFAPA) syndrome investigated the impact of the condition on children and found that is was associated with a reduction…
Continue ReadingStudy Finds Children with PFAPA Syndrome Have a Reduced Health-Related Quality of Life
A recently published paper called ‘Biallelic loss of human CTNNA2, encoding αN-catenin, leads to ARP2/3 complex overactivity and disordered cortical neuronal migration’ outlines new research into the genetic basis of…
Continue ReadingThe Genetic and Developmental Processes Underlying Pachygyria are Explored in a Recent Study
Gemphire Therapeutics Inc. has been recommended to stop a clinical trial by the Data and Safety Monitoring Board at Emory University School of Medicine. The clinical trial, which ran into…
Continue ReadingA Clinical Trial of Gemcabene in Paediatric Patients with Non-Alcoholic Fatty Liver Disease Has Been Stopped Following Safety Concerns
The company Epizyme has announced the results of a Phase 2 clinical study of its lead candidate drug, tazemetostat, in the treatment of relapsed or refractory malignant mesothelioma with loss…
Continue ReadingThe Results of a Study Evaluating a Drug For Mesothelioma Have Been Announced
A motor neurone disease clinical drug trial will take place in Scotland for the first time in more than twenty years. This study is the first step in a broader…
Continue ReadingOver £1.5 Million Has Been Committed to Funding MND Clinical Trials in Scotland
The top-line results of a pivotal Phase 3 study investigating the drug recorlevTM (levoketoconazole) in patients with endogenous Cushing’s syndrome have been released. The source article, which contains more detailed information,…
Continue ReadingResults from a Phase 3 Study of Recorlev as a Potential Treatment for Cushing’s Syndrome Have Been Released
An investigational drug called ALT-P7 is being developed as a potential medicine for certain forms of cancer. The drug has received Orphan Drug Designation for the treatment of gastric cancer…
Continue ReadingOrphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer
The US FDA has awarded Orphan Drug status to the investigational drug NSI-189 for use by people with Angelman syndrome. You can read the source article here, at Nasdaq. About…
Continue ReadingOrphan Drug Designation Awarded to an Investigational Drug for Angelman Syndrome
The US Food and Drug Administration (FDA) has awarded Orphan Drug Designation to the experimental drug ALN-TTRsc02. Alnylam Pharmaceuticals Inc. is developing ALN-TTRsc02 as a possible treatment for transthyretin-mediated amyloidosis.…
Continue ReadingThe FDA Has Granted Orphan Drug Status to an Experimental Drug to Treat Amyloidosis
The European Medicines Agency has awarded Orphan Drug designation to selumetinib for the treatment of neurofibromatosis type 1. You can read the source press release here, on Merck’s website. About…
Continue ReadingOrphan Drug Designation Has Been Awarded to Selumetinib for the Treatment of Neurofibromatosis Type 1
Ehlers-Danlos syndromes (EDS) are a group of rare conditions that affect the connective tissue and can be inherited. Connective tissue lies between tissues and organs throughout the body and helps…
Continue ReadingThere is No Ehlers-Danlos Syndrome Nutshell, But Here’s an Overview of the Known Types
According to a source article on Business Wire that can be found here, the Committee for Orphan Medicinal Products (part of the European Medicines Agency) has recommended that the experimental…
Continue ReadingOMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation
According to a source article that can be found here on Ultragenyx’s website, the first patient has been dosed in a trial of an investigational gene therapy called DTX401 that…
Continue ReadingThe First Patient Has Been Dosed on a Clinical Trial of an Investigational Gene Therapy for the Treatment of GSDIa
A study is planned to investigate the effects of the experimental drug PTC596 in children with recently diagnosed diffuse intrinsic pontine glioma and high-grade glioma. The study is made up…
Continue ReadingA Planned Study Will Investigate the Effects of an Investigational Drug in Children with Glioma
The first patient has been treated in the Empowers study, a clinical trial investigating an experimental gene editing therapy for the treatment of mucopolysaccharidosis type I. The source article, which…
Continue ReadingThe First Patient Has Been Treated in a Gene Therapy Study for MPS I
A series called ‘Gonads’ by RadioLab is looking into human reproduction. Their second episode, which is the source used for this article, can be found here. It explores the story of Greg…
Continue ReadingHow Annie Became the First Woman to Have a Child After Freezing Her Ovary
A study of Lynparza (olaparib) in combination with abiraterone for the treatment of metastatic castration-resistant prostate cancer has shown promising results. The full article can be read here, at Bio…
Continue ReadingResearchers Say The Drug Lynparza May Be Useful as a Prostate Cancer Treatment
Results from two studies looking at the effects of an experimental drug (bardoxolone) on kidney function in patients with chronic kidney disease (CKD) have been released. One of the studies…
Continue ReadingResults From Studies of an Experimental Drug for Chronic Kidney Disease Have Been Announced
An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…
Continue ReadingOctober 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
The first patient has been enrolled onto a Phase 3 clinical trial investigating topical dermal reproxalap as a possible treatment for Sjögren-Larsson syndrome associated ichthyosis. The original article can be read…
Continue ReadingThe First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
Researchers have investigated whether self-management electronic health (eHealth) interventions, such as text messaging, apps, and online cognitive-behavioural therapy, should be used to help patients with sickle cell disease self-manage the…
Continue ReadingResearchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.